{"id":15389,"date":"2024-07-10T10:24:34","date_gmt":"2024-07-10T09:24:34","guid":{"rendered":"https:\/\/www.adas.org.rs\/?p=15389"},"modified":"2025-11-19T11:04:45","modified_gmt":"2025-11-19T10:04:45","slug":"kenijski-maratonac-lorens-cerono-dobio-je-7-godisnju-kaznu-zbog-krsenja-dopinga","status":"publish","type":"post","link":"https:\/\/www.adas.org.rs\/en\/iz_medija\/2024\/07\/10\/kenijski-maratonac-lorens-cerono-dobio-je-7-godisnju-kaznu-zbog-krsenja-dopinga\/","title":{"rendered":"Kenyan marathoner Lawrence Cherono gets 7-year ban for doping violation"},"content":{"rendered":"<p><\/p>\n<p>A Kenyan winner of both the Boston and Chicago marathons was given a seven-year suspension on Wednesday by an international doping watchdog.<\/p>\n<p>The ban on Lawrence Cherono by the Athletics Integrity Unit stems from a positive test for trimetazidine, a banned substance, in an out-of-competition sample collected in July 2022.<\/p>\n<p>\u201cThe 35-year-old Kenyan, a two time major marathon winner and 12th fastest marathon runner of all time, was found to have breached Anti-Doping Rule (ADR) 2.1, relating to the Presence of a Prohibited Substance,\u201d the unit said in a statement.<\/p>\n<p>https:\/\/www.aa.com.tr\/en\/africa\/kenyan-marathoner-lawrence-cherono-gets-7-year-ban-for-doping-violation\/3271519<\/p>","protected":false},"excerpt":{"rendered":"<p>A Kenyan winner of both the Boston and Chicago marathons was given a seven-year suspension on Wednesday by an international doping watchdog. The ban on Lawrence Cherono by the Athletics Integrity Unit stems from a positive test for trimetazidine, a banned substance, in an out-of-competition sample collected in July 2022. \u201cThe 35-year-old Kenyan, a two <a href=\"https:\/\/www.adas.org.rs\/en\/iz_medija\/2024\/07\/10\/kenijski-maratonac-lorens-cerono-dobio-je-7-godisnju-kaznu-zbog-krsenja-dopinga\/\" class=\"more-link\">&#8230;<span class=\"screen-reader-text\">  Kenyan marathoner Lawrence Cherono gets 7-year ban for doping violation<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-15389","post","type-post","status-publish","format-standard","hentry","category-iz_medija"],"_links":{"self":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts\/15389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/comments?post=15389"}],"version-history":[{"count":4,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts\/15389\/revisions"}],"predecessor-version":[{"id":16831,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/posts\/15389\/revisions\/16831"}],"wp:attachment":[{"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/media?parent=15389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/categories?post=15389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.adas.org.rs\/en\/wp-json\/wp\/v2\/tags?post=15389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}